Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week
Executive Summary
The combined Glaxo SmithKline U.S. sales force would be able to call on 250,000 physicians during the first week of a major product launch, the companies told a Jan. 17 London press briefing on their proposed merger.
You may also be interested in...
Novartis, Bristol To Share Zelmac; Novartis Opts For Partnership, Not Merger
Novartis' agreement with Bristol Myers-Squibb to co-promote the irritable bowel syndrome treatment Zelmac (tegaserod) accomplishes one objective of the Swiss company's attempts to grow via a merger in the U.S.
Novartis, Bristol To Share Zelmac; Novartis Opts For Partnership, Not Merger
Novartis' agreement with Bristol Myers-Squibb to co-promote the irritable bowel syndrome treatment Zelmac (tegaserod) accomplishes one objective of the Swiss company's attempts to grow via a merger in the U.S.
Novartis Zelmac Co-Promotion Is Possibility, Firm Indicates
Novartis may consider a co-promotion partner for the irritable bowel syndrome therapy Zelmac (tegaserod) in the U.S., CEO Daniel Vasella indicated during an Aug. 21 conference call with analysts.